Observational studyJournal of immunology research2022

The NLRP3 Genetic Variant (rs10754555) Reduces the Risk of Adverse Outcome in Middle-Aged Patients with Chronic Coronary Syndrome.

Trine B Opstad et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.